Stem cells in melanoma development

Marianna Sabatino, David F. Stroncek, Harvey Klein, Francesco M. Marincola, Ena Wang

Research output: Contribution to journalShort survey

15 Citations (Scopus)

Abstract

Cutaneous melanoma is a significant health problem worldwide. Available treatments can induce objective tumor regression in a small percent of patients, but these responses are not always associated with improved long-term survival. The resistance of melanoma to therapy and its predestined recurrence are related to the genetic heterogeneity and genomic instability of the tumor. For many years these genetic alterations were thought to be linked to the accumulation of random mutations in functionally differentiated cells which transform them into malignant cells that have lost their ability to differentiate and have acquired drug resistance. In the last few years it has been largely demonstrated that melanoma as other solid tumors contains a subpopulation of cells (CSCs) considered the source of the primary tumor mass, of new tumor nodules and responsible for drug resistance and cancer recurrence. In this review, we provide an overview of findings and advances in CSCs research that are relevant to the initiation, natural history, and the response to treatment of malignant melanoma.

Original languageEnglish
Pages (from-to)119-125
Number of pages7
JournalCancer Letters
Volume279
Issue number2
DOIs
Publication statusPublished - 8 Jul 2009
Externally publishedYes

Fingerprint

Melanoma
Stem Cells
Neoplasms
Drug Resistance
Recurrence
Genetic Heterogeneity
Genomic Instability
Natural History
Therapeutics
Skin
Survival
Research

Keywords

  • Cancer stem cells
  • Melanoma stem cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sabatino, M., Stroncek, D. F., Klein, H., Marincola, F. M., & Wang, E. (2009). Stem cells in melanoma development. Cancer Letters, 279(2), 119-125. https://doi.org/10.1016/j.canlet.2008.10.039

Stem cells in melanoma development. / Sabatino, Marianna; Stroncek, David F.; Klein, Harvey; Marincola, Francesco M.; Wang, Ena.

In: Cancer Letters, Vol. 279, No. 2, 08.07.2009, p. 119-125.

Research output: Contribution to journalShort survey

Sabatino, M, Stroncek, DF, Klein, H, Marincola, FM & Wang, E 2009, 'Stem cells in melanoma development', Cancer Letters, vol. 279, no. 2, pp. 119-125. https://doi.org/10.1016/j.canlet.2008.10.039
Sabatino M, Stroncek DF, Klein H, Marincola FM, Wang E. Stem cells in melanoma development. Cancer Letters. 2009 Jul 8;279(2):119-125. https://doi.org/10.1016/j.canlet.2008.10.039
Sabatino, Marianna ; Stroncek, David F. ; Klein, Harvey ; Marincola, Francesco M. ; Wang, Ena. / Stem cells in melanoma development. In: Cancer Letters. 2009 ; Vol. 279, No. 2. pp. 119-125.
@article{9df1264a0d574f8697a68bd44232f867,
title = "Stem cells in melanoma development",
abstract = "Cutaneous melanoma is a significant health problem worldwide. Available treatments can induce objective tumor regression in a small percent of patients, but these responses are not always associated with improved long-term survival. The resistance of melanoma to therapy and its predestined recurrence are related to the genetic heterogeneity and genomic instability of the tumor. For many years these genetic alterations were thought to be linked to the accumulation of random mutations in functionally differentiated cells which transform them into malignant cells that have lost their ability to differentiate and have acquired drug resistance. In the last few years it has been largely demonstrated that melanoma as other solid tumors contains a subpopulation of cells (CSCs) considered the source of the primary tumor mass, of new tumor nodules and responsible for drug resistance and cancer recurrence. In this review, we provide an overview of findings and advances in CSCs research that are relevant to the initiation, natural history, and the response to treatment of malignant melanoma.",
keywords = "Cancer stem cells, Melanoma stem cells",
author = "Marianna Sabatino and Stroncek, {David F.} and Harvey Klein and Marincola, {Francesco M.} and Ena Wang",
year = "2009",
month = "7",
day = "8",
doi = "10.1016/j.canlet.2008.10.039",
language = "English",
volume = "279",
pages = "119--125",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Stem cells in melanoma development

AU - Sabatino, Marianna

AU - Stroncek, David F.

AU - Klein, Harvey

AU - Marincola, Francesco M.

AU - Wang, Ena

PY - 2009/7/8

Y1 - 2009/7/8

N2 - Cutaneous melanoma is a significant health problem worldwide. Available treatments can induce objective tumor regression in a small percent of patients, but these responses are not always associated with improved long-term survival. The resistance of melanoma to therapy and its predestined recurrence are related to the genetic heterogeneity and genomic instability of the tumor. For many years these genetic alterations were thought to be linked to the accumulation of random mutations in functionally differentiated cells which transform them into malignant cells that have lost their ability to differentiate and have acquired drug resistance. In the last few years it has been largely demonstrated that melanoma as other solid tumors contains a subpopulation of cells (CSCs) considered the source of the primary tumor mass, of new tumor nodules and responsible for drug resistance and cancer recurrence. In this review, we provide an overview of findings and advances in CSCs research that are relevant to the initiation, natural history, and the response to treatment of malignant melanoma.

AB - Cutaneous melanoma is a significant health problem worldwide. Available treatments can induce objective tumor regression in a small percent of patients, but these responses are not always associated with improved long-term survival. The resistance of melanoma to therapy and its predestined recurrence are related to the genetic heterogeneity and genomic instability of the tumor. For many years these genetic alterations were thought to be linked to the accumulation of random mutations in functionally differentiated cells which transform them into malignant cells that have lost their ability to differentiate and have acquired drug resistance. In the last few years it has been largely demonstrated that melanoma as other solid tumors contains a subpopulation of cells (CSCs) considered the source of the primary tumor mass, of new tumor nodules and responsible for drug resistance and cancer recurrence. In this review, we provide an overview of findings and advances in CSCs research that are relevant to the initiation, natural history, and the response to treatment of malignant melanoma.

KW - Cancer stem cells

KW - Melanoma stem cells

UR - http://www.scopus.com/inward/record.url?scp=67349278038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349278038&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2008.10.039

DO - 10.1016/j.canlet.2008.10.039

M3 - Short survey

C2 - 19095348

AN - SCOPUS:67349278038

VL - 279

SP - 119

EP - 125

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -